The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. Read the full story
The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. Read the full story
Bavarian Nordic Pharmaceuticals has announced only 1 M&A deal since 2009; the acquisition of BN Immuno Therapeutics. Read the full story
PaxVax has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections. Read the full story
Cubist Pharmaceuticals is a biopharmaceutical company developing and commercializing medications for acute care in hospitals and surgical environments. Read the full story
The Infectives Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the infectives/infection/infectious partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story